Neil Guha

Contact

• workRoom Nottingham Digestive Diseases Centre BRU, Level E, West Block QMC
  Queen's Medical Centre
  Nottingham
  NG7 2UH
  UK
• work0115 924 9924 70609
• fax0115 970 9955
• neil.guha@nottingham.ac.uk

Expertise Summary

Dr Neil Guha is a Clinical Associate Professor in Hepatology at the University of Nottingham. He trained at Guy's and St. Thomas's hospitals and began his postgraduate career in hepatology at St. Mary's Hospital, London. His doctoral thesis, awarded by the University of Southampton, focussed on non-invasive biomarkers of liver fibrosis. He completed his clinical training at the Southampton Liver Unit and was appointed as a clinical lecturer by the University of Southampton in 2008. He moved to Nottingham in 2009 to commence his current post at the National Institute of Health Research Nottingham Digestive Diseases Centre Biomedical Research Unit. His research continues to focus on biomarkers of liver fibrosis with current work in serum markers, hypothesis generating technologies, imaging modalities and utilisation of biomarkers in clinical practice.

Research Summary

• Non-invasive assessment of liver fibrosis
• Diagnostic and prognostic liver biomarkers
• Novel techniques to assess liver related outcomes

Recent Publications

• HAMMOND, J S, GUHA, I N, BECKINGHAM, I J and LOBO, D N, 2011. Prediction, prevention and management of postresection liver failure. The British Journal Of Surgery.
• GUHA, INDRA NEIL, MYERS, ROBERT P, PATEL, KEYUR and TALWALKAR, JAYANT A, 2011. Biomarkers of liver fibrosis: What lies beneath the receiver operating characteristic curve? Hepatology (Baltimore, Md.). 54(4), 1454-62
• GUHA, INDRA NEIL, BOKHANDI, SUMIT, AHMAD, ZAHEER, SHERON, NICK, COPE, RICHARD, MARSHALL, CAROLINE and VELDTMAN, GRUSCHEN, 2011. Structural and functional uncoupling of liver performance in the Fontan circulation. International journal of cardiology.
• PARKES, J, GUHA, I N, RODERICK, P, HARRIS, S, CROSS, R, MANOS, M M, IRVING, W, ZAITOUN, A, WHEATLEY, M, RYDER, S and ROSENBERG, W, 2010. Enhanced Liver Fibrosis (ELF) test accurately identifies liver fibrosis in patients with chronic hepatitis C. Journal of viral hepatitis.

• View all publications

• HAMMOND, J S, GUHA, I N, BECKINGHAM, I J and LOBO, D N, 2011. Prediction, prevention and management of postresection liver failure. The British Journal Of Surgery.
• GUHA, INDRA NEIL, MYERS, ROBERT P, PATEL, KEYUR and TALWALKAR, JAYANT A, 2011. Biomarkers of liver fibrosis: What lies beneath the receiver operating characteristic curve? Hepatology (Baltimore, Md.). 54(4), 1454-62
• GUHA, INDRA NEIL, BOKHANDI, SUMIT, AHMAD, ZAHEER, SHERON, NICK, COPE, RICHARD, MARSHALL, CAROLINE and VELDTMAN, GRUSCHEN, 2011. Structural and functional uncoupling of liver performance in the Fontan circulation. International journal of cardiology.
• PARKES, J, GUHA, I N, RODERICK, P, HARRIS, S, CROSS, R, MANOS, M M, IRVING, W, ZAITOUN, A, WHEATLEY, M, RYDER, S and ROSENBERG, W, 2010. Enhanced Liver Fibrosis (ELF) test accurately identifies liver fibrosis in patients with chronic hepatitis C. Journal of viral hepatitis.
• BROWN, MATTHEW R L, JONES, GRAEME, NASH, KATHRYN L, WRIGHT, MARK and GUHA, INDRA NEIL, 2010. Antibiotic prophylaxis in variceal hemorrhage: timing, effectiveness and Clostridium difficile rates. World journal of gastroenterology : WJG. 16(42), 5317-23
• KNAPP, SUSANNE, WARSHOW, USAMA, HEGAZY, DOHA, BRACKENBURY, LOUISE, GUHA, I NEIL, FOWELL, ANDREW, LITTLE, ANN-MARGARET, ALEXANDER, GRAEME J, ROSENBERG, WILLIAM M C, CRAMP, MATTHEW E and KHAKOO, SALIM I, 2010. Consistent beneficial effects of killer cell immunoglobulin-like receptor 2DL3 and group 1 human leukocyte antigen-C following exposure to hepatitis C virus. Hepatology (Baltimore, Md.). 51(4), 1168-75
• GUHA, INDRA NEIL, 2009. Back to the future with noninvasive biomarkers of liver fibrosis. Hepatology (Baltimore, Md.). 49(1), 9-11
• GUHA, INDRA NEIL, PARKES, JULIE, RODERICK, PAUL, CHATTOPADHYAY, DIPANKER, CROSS, RICHARD, HARRIS, SCOTT, KAYE, PHILIP, BURT, ALASTAIR D, RYDER, STEVE D, AITHAL, GURUPRASAD P, DAY, CHRISTOPHER P and ROSEN, 2008. Noninvasive markers of fibrosis in nonalcoholic fatty liver disease: Validating the European Liver Fibrosis Panel and exploring simple markers. Hepatology (Baltimore, Md.). 47(2), 455-60
• GUHA, I N and ROSENBERG, W M, 2008. Noninvasive assessment of liver fibrosis: serum markers, imaging, and other modalities. Clinics in liver disease. 12(4), 883-900, x
• MUDDU, AJAY K, GUHA, INDRA NEIL, ELSHARKAWY, AHMED M and MANN, DEREK A, 2007. Resolving fibrosis in the diseased liver: translating the scientific promise to the clinic. The international journal of biochemistry & cell biology. 39(4), 695-714
• GUHA, I N and ROSENBERG, W M, 2006. Future use of the Glasgow alcoholic hepatitis score. Gut. 55(1), 135-6
• GUHA, I N, PARKES, J, RODERICK, P R, HARRIS, S and ROSENBERG, W M, 2006. Non-invasive markers associated with liver fibrosis in non-alcoholic fatty liver disease. Gut. 55(11), 1650-60
• PARKES, JULIE, GUHA, INDRA NEIL, RODERICK, PAUL and ROSENBERG, WILLIAM, 2006. Performance of serum marker panels for liver fibrosis in chronic hepatitis C. Journal of hepatology. 44(3), 462-74
• GUHA, I N, STEDMAN, B, IREDALE, J P and SHERON, N, 2005. Case report of an arterioportal fistula, presenting with accelerated decompensation and sepsis, twenty-six years after initial liver biopsy. Hepatology research : the official journal of the Japan Society of Hepatology. 32(4), 252-5
• GUHA, INDRA NEIL and MOORE, KEVIN, 2003. F2-isoprostanes and the liver. Prostaglandins & other lipid mediators. 72(1-2), 73-84